CDSCO Drug Name,FDA Drug Name,Similarity Score,CDSCO Approval Date,FDA Approval Date,CDSCO Indication,FDA Indication
Acetylcysteine,Acetylcysteine,1,1/3/66,23/01/2004,Mucolytic enzyme,"For the use of Acetadote(registered TM) Injection, administered intravenously within 8 to 10 hours after ingestion of a potentially heptotoxic quantity of acetaminophen, to prevent or lessen hepatic injur"
Azacitidine,Azacitidine,1,29/04/2014,20/05/2022,Treatment of myelodysplastic syndromes in adults,Treatment of pediatric patients aged one month and older with newly diagnosed juvenile myelomonocytic leukemia (JMML)
Nintedanib,Nintedanib,1,11/3/16,6/9/19,Treatment of idiopathic pulmonary fibrosis,OFEV is indicated to slow the rate of decline in pulmonary function in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD).
Ruxolitinib,Ruxolitinib,1,28/01/2013,22/09/2021,Treatment of myelofibrosis,Treatment of chronic graft-versus-host disease (cGVHD) after failure of one or two lines of systemic therapy in adult and pediatric patients 12 years and older
Ruxolitinib,Ruxolitinib Phosphate,0.9047619047619048,28/01/2013,16/11/2011,Treatment of myelofibrosis,"Treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis"
Sofosbuvir,Sofosbuvir,1,13/01/2015,7/4/17,Treatment of chronic hepatitis C (with other medications),Treatment of chronic HCV genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin
Aripiprazole,Aripiprazole,1,23/02/2004,12/12/14,Treatment of schizophrenia,Treatment of pediatric patients with Tourette's
Mitoxantrone,Mitoxantrone,1,1/3/89,13/10/2000,,"Reducing neurologic disability and/or the frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly adnormal between relapses)."
Mitoxantrone,Mitoxantrone Hcl,0.95,1/3/89,23/12/1987,,
Recombinant Human Erythropoietin,Recombinant Human Antithrombin,0.9127564102564102,7/2/00,6/2/09,Autologous blood donation in anaemia due to renal failure or cancer,"Prevention of peri-operative and peri-partum thromboembolic events, in hereditary antithrombin deficient patients."
Tinidazole,Tinidazole,1,1/12/83,17/05/2004,,Treatment of giardiasis caused by G. duodenalis (also termed G. lamblia) in both adults and pediatric patients older than three years of age
Imatinib Mesylate,Imatinib Mesylate,1,11/8/11,19/12/2008,"Treatment of Ph+ALL (newly diagnosed, relapsed/refractory), CML, GIST, other approved indications",Adjuvant treatment of adult patients following complete resection Kit (CD 117) positive gastrointestinal stromal tumors (GIST).
Fosphenytoin Sodium,Fosphenytoin,0.9263157894736842,1/10/02,5/8/96,"Status epilepticus, seizure prevention/treatment during neurosurgery or head injury",For the control of generalized convulsive status epilepticus.
Rifaximin,Rifaximin,1,18/08/2011,24/03/2010,Reduction in risk of overt hepatic encephalopathy recurrence in adults (≥18 years),Reduction in the risk of overt hepatic encephalopathy (HE) recurrence in patients greater than or equal to 18 years of age
Dexamethasone,Dexamethasone,1,2/11/04,3/10/19,"Steroid-responsive neoplastic disease (leukemias, lymphomas) in adults (by oncologists only)",HEMADY is indicated in combination with other anti-myeloma products for the treatment of adults with multiple myeloma
Etanercept,Etanercept,1,7/12/01,27/05/1999,Reduction of moderate to severe active rheumatoid arthritis after inadequate response to DMARDs,Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in patients ages 2 and older
Abatacept,Abatacept,1,10/4/09,15/12/2021,Reducing signs and symptoms of moderate to severe active polyarticular juvenile idiopathic arthritis,"prophylaxis of acute graft versus host disease (aGVHD), in combination with a calcineurin inhibitor and methotrexate, in adults and pediatric patients 2 years of age and older undergoing hematopoietic stem cell transplantation (HSCT) from a matched or 1 allele-mismatched unrelated-donor"
Lamotrigine,Lamotrigine,1,5/4/10,24/08/1998,Same as approved (refer to main lamotrigine indication),Adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients.
Methotrexate,Methotrexate,1,25/11/2005,25/04/2017,Psoriasis,"Management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs)."
Methotrexate,Methotrexate Sodium,0.9263157894736842,25/11/2005,7/4/88,Psoriasis,For the use of high dose methotrexate with leucovorin rescue in patients with non-metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor.
Somatropin (Rdna),Somatropin,0.9333333333333333,25/11/2004,30/12/1996,"Adult or childhood growth hormone deficiency, idiopathic short stature",Treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed.
Somatropin (Rdna),Somatropin (Rdna Origin),0.9363636363636364,25/11/2004,22/12/1999,"Adult or childhood growth hormone deficiency, idiopathic short stature",Long-term treatment of growth failure due to a lack of adequate endogenous growth hormone secetion for once- or twice-a-month administration.
Somatropin (Rdna),Somatropin [Rdna],1,25/11/2004,25/07/2001,"Adult or childhood growth hormone deficiency, idiopathic short stature",For long-term treatment of growth failure in children born small for gestational age who fail to manifest catch-up growth by two years of age.
Pemetrexed,Pemetrexed Disodium,0.9052631578947368,21/08/2006,4/2/04,Treatment of cancer,Treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery
Leuprolide Acetate,Leuprolide Acetate,1,3/12/03,16/04/1993,Treatment of advanced prostatic cancer,Treatment of children with central precocious puberty
Topiramate,Topiramate,1,24/12/2001,28/08/2001,,As adjunctive therapy in patients two years and older with siezures associated with Lennox-Gastaut syndrome.
Afatinib,Afatinib,1,30/12/2014,15/04/2016,Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation,"Treatment of patients with metastatic, squamous, non-small cell lung cancer progressing after platinum-based chemotherapy"
Etidronate Disodium,Etidronate Disodium,1,10/3/95,21/04/1987,Treatment of hypercalcemia induced by malignant disorders,
Ibuprofen,Ibuprofen Lysine,0.9125,1/4/79,13/04/2006,,"For closure of a clinically significant patent ductus arteriosus in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective"
Ofloxacin,Ofloxacin,1,1/5/91,22/05/1996,"Treatment of respiratory, urinary tract, gynecological, skin and soft tissue infections",Treatment of bacterial corneal ulcers.
Trabectedin,Trabectedin,1,1/4/09,23/10/2015,"Treatment of advanced soft tissue sarcoma after failure of anthracyclines and ifosfamide, or when unsuited to receive these agents",For the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen
"Tranexamic Acid, Mefenamic Acid",Tranexamic Acid,0.9,22/02/2005,30/12/1986,Treatment of primary dysmenorrhoea and pain associated with menorrhagia in women,Treatment of patients with hemophilia for short term use (2 to 8 days) before and after tooth extraction to reduce or prevent hemorrhage abd reduce the need for replacement therapy
Tretinoin,Tretinoin,1,1/7/74,22/11/1995,Treatment of acne vulgaris,Induction of remission in patients with acute promyelocytic leukemia who are refractory to or unable to tolerate anthracycline based cytotoxic chemotherapeutic regimens.
"Albendazole, Ivermectin",Albendazole,0.9,25/04/2009,11/6/96,"Treatment of intestinal helminthes and suppression of microfilaraemia, especially with bancrofti infections","Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium."
"Difluprednate, Moxifloxacin",Difluprednate,0.9,22/09/2011,13/06/2012,Treatment of steroid responsive inflammatory ocular conditions with risk of bacterial infection,Treatment of endogenous anterior uveitis
Paclitaxel,Paclitaxel,1,23/08/2006,4/8/97,Treatment of metastatic breast cancer,For the second line treatment of AIDS-related Kaposi's sarcoma.
Rifabutin,Rifabutin,1,19/07/2007,23/12/1992,Treatment of pulmonary tuberculosis in HIV co-infected patients,Prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infections.
Tacrolimus,Tacrolimus,1,24/04/2010,29/03/2006,,Prophylaxis of organ rejection in patients receiving allogenic heart transplants.
Aztreonam,Aztreonam,1,1/11/02,22/02/2010,"Treatment of urinary tract infection, lower respiratory tract infection, septicemia, skin and skin structure infections, intra-abdominal infections, gynecological infections",To improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa
Balsalazide,Balsalazide Disodium,0.91,11/12/02,20/12/2006,Treatment of mild to moderately active ulcerative colitis,Treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older. Safety and Effectiveness of Colazal beyond 8 weeks in children (ages 5-17) and 12 weeks in adults have not been established.
Lenalidomide,Lenalidomide,1,22/04/2008,29/06/2006,In combination with dexamethasone for treatment of multiple myeloma in previously treated patients,For use in combination with dexamethasone for the treatment of multiple myeloma patients who have received at least one prior therapy
Clonidine,Clonidine,1,1/7/75,2/10/96,Treatment of hypertension,In combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.
Decitabine,Decitabine,1,28/04/2009,2/5/06,"Treatment of myelodysplastic syndromes (MDS), including all subtypes","for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups"
Eltrombopag Olamine,Eltrombopag,0.9157894736842105,7/4/14,16/11/2018,Treatment of thrombocytopenia in chronic HCV infection to enable or optimize interferon-based therapy,PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
"Levodopa, Carbidopa",Levodopa And Carbidopa,0.9191919191919192,1/12/83,9/1/15,Treatment of Parkinson's disease,Treatment of motor flucuations in patients with advanced Parkinson's disease
Midazolam,Midazolam,1,15/04/1997,17/05/2019,"General anaesthesia, preoperative sedation, conscious sedation prior to diagnostic or endoscopic procedure","NAYZILAM is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older."
Deferasirox,Deferasirox,1,17/08/2007,18/05/2017,As approved,Treatment of chronic iron overload in patients 10 years of age and older with non-transfusion-dependent thalassemia (NTDT) syndromes and with a liver iron concentration (LIC) of at least 5 milligrams of iron per gram of liver dry weight (mg Fe/g dw) and a serum ferritin greater than 300 mcg/L.
Allopurinol,Allopurinol Sodium,0.9222222222222222,22/11/2002,17/05/1996,Treatment and prophylaxis of gout,"Management of patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy."
Sorafenib,Sorafenib,1,1/8/07,16/11/2007,Treatment of advanced renal cell carcinoma,Treatment of unresectable hepatocellular carcinoma
Everolimus,Everolimus,1,16/05/2009,26/02/2016,Treatment of advanced renal cell carcinoma,"Treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease; and treatment of adult patients with progressive, well-differentiated, non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin, with unresectable, locally advanced or metastatic disease."
Gefitinib,Gefitinib,1,17/02/2004,13/07/2015,Anticancer,For the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test
Rosuvastatin Calcium,Rosuvastatin,0.92,24/05/2010,27/05/2016,"Risk reduction of myocardial infarction, stroke, and arterial revascularization procedures in patients without clinically evident CHD but with multiple risk factors","An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis)."
Sirolimus,Sirolimus,1,31/12/2002,28/05/2015,Prophylaxis of organ rejection in patients receiving renal transplant with cyclosporins and corticosteroids,Treatment of lymphangioleiomyomatosis (LAM)
Bortezomib,Bortezomib,1,5/9/07,8/12/06,Treatment of mantle cell lymphoma in patients with at least one prior therapy,Treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.
Dasatinib,Dasatinib,1,30/08/2006,9/11/17,"Treatment of adults with chronic, accelerated, or myeloid/lymphoid blast phase chronic myeloid leukemia (CML)",Treatment of pediatric patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
Desmopressin,Desmopressin Acetate,0.92,8/5/08,7/3/94,Treatment of diabetes insipidus and nocturnal enuresis,Treatment of patients with hemophilia A or von Willebrand's disease (type I) whose factor VIII coagulant activity level is greater than 5%.
Miltefosine,Miltefosine,1,15/03/2002,19/03/2014,Treatment of visceral leishmaniasis,"Treatment of visceral leishmaniasis due to Leishmania donovani; cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis; and mucosal leishmaniasis due to Leishmania braziliensis."
Amiodarone,Amiodarone Hcl,0.9428571428571428,1/4/90,3/8/95,Treatment of ventricular and supraventricular arrhythmia where other drugs cannot be used; arrhythmia with Wolff-Parkinson-White syndrome,For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.
Doxorubicin,Doxorubicin Liposome,0.91,1/8/76,28/06/1999,,"Treatment of metastatic carcinoma of the ovary in patients with disease that is refractory to both paclitaxel- and platinium-based chemotherapy regimens. Refractory disease is defined as disease that has progressed while on treatment, or within 6 months of completing treatment."
Pentosan Polysulfate Sodium,Pentosan Polysulfate Sodium,1,11/5/10,26/09/1996,Relief of bladder pain or discomfort associated with interstitial cystitis,Relief of bladder pain or discomfort associated with interstitial cystitis.
Albendazole,Albendazole,1,28/11/2011,11/6/96,"Treatment of systemic helminth infections: neurocysticercosis, echinococcosis","Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium."
"Rosuvastatin, Ezetimibe",Rosuvastatin,0.9090909090909091,5/12/11,27/05/2016,Treatment of primary hypercholesterolemia,"An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis)."
"Artemether, Lumefantrine",Artemether/Lumefantrine,1,26/12/2002,7/4/09,Treatment of p. falciparum malaria resistant to chloroquine and sulphadoxine-pyrimethamine,"Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum"
Fludarabine,Fludarabine Phosphate,0.9047619047619048,1/4/05,18/04/1991,Treatment of B-cell chronic lymphocytic leukaemia,
Ibrutinib,Ibrutinib,1,7/10/15,2/8/17,"Treatment of adult patients with mantle cell lymphoma (MCL), CLL after prior therapy, or CLL with 17p deletion",Treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more lines of systemic therapy.
Caffeine Citrate,Caffeine,0.9,18/07/2009,21/09/1999,,Short term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age.
Lidocaine,Lidocaine Patch,0.92,17/06/2010,19/03/1999,Relief of pain associated with post-herpetic neuralgia; apply only to intact skin,
Posaconazole,Posaconazole,1,20/12/2011,17/06/2021,Treatment of zygomycosis refractory or intolerant to other therapy,Treatment of invasive aspergillosis in adults and pediatric patients 13 years of age and older
Amphotericin B,Amphotericin B Lipid Complex,0.9,18/07/2009,18/10/1996,Febrile neutropenia in cancer patients,Treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin B therapy.
Ambrisentan,Ambrisentan,1,28/05/2010,15/06/2007,Treatment of pulmonary arterial hypertension (WHO Group I) in patients with class II or III symptoms to improve exercise capacity and delay clinical worsening,Treatment of pulmonary arterial hypertension (WHO group I) in patients with WHO class II or III symptoms to improve exercise capacity and delay clinical worsening
Bendamustine Hydrochloride,Bendamustine Hydrochloride,1,19/05/2009,31/10/2008,Treatment of chronic lymphocytic leukemia,Treatment of Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
Clofazimine,Clofazimine,1,1/9/69,15/12/1986,Anti-leprosy drug,
"Ledipasvir, Sofosbuvir",Ledipasvir/Sofosbuvir,1,8/12/15,28/08/2019,Treatment of chronic hepatitis C genotype 1 infection in adults,"HARVONI is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, genotype 1 infection with decompensated cirrhosis, for use in combination with ribavirin, and genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis, for use in combination with ribavirin"
Tadalafil,Tadalafil,1,27/02/2013,22/05/2009,Treatment of erectile dysfunction; erectile dysfunction with benign prostatic hyperplasia,Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability
Tolvaptan,Tolvaptan,1,6/9/12,23/04/2018,"Treatment of hypervolemic and euvolemic hyponatremia, including patients with heart failure, cirrhosis, SIADH",JYNARQUE is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD)
Budesonide,Budesonide,1,5/8/05,15/12/2021,Treatment of ulcerative colitis involving rectal and rectosigmoid diseases,"to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) > or = 1.5 g/g"
Octreotide,Octreotide,1,1/8/05,25/11/1998,—,Supression of severe diarrhea and flushing associated with malignant carcinoid syndrome.
Gabapentin,Gabapentin,1,15/12/2006,28/01/2011,Treatment of neuropathic pain; adjunctive therapy for partial seizures in adults,For the management of postherpetic neuralgia
Gabapentin,Gabapentin Enacarbil,0.9,15/12/2006,6/6/12,Treatment of neuropathic pain; adjunctive therapy for partial seizures in adults,Management of postherpetic neuralgia in adults.
Exemestane,Exemestane,1,29/08/2009,21/10/1999,"Adjuvant treatment of postmenopausal women with estrogen receptor-positive early breast cancer after 2–3 years of tamoxifen, switching to exemestane to complete 5 years of therapy",Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy.
Diazepam,Diazepam (,1,17/06/1999,10/1/20,Emergency treatment of convulsions; chronic prophylaxis against febrile seizures,"Acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 6 years of age and older."
Diazepam,Diazepam Viscous,0.9,17/06/1999,29/07/1997,Emergency treatment of convulsions; chronic prophylaxis against febrile seizures,
Mifepristone,Mifepristone,1,13/02/2002,17/02/2012,Medical termination of intrauterine pregnancy through 49 days (by gynecologist only),for the control of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery.
Ribavirin,Ribavirin,1,1/11/06,29/07/2003,"Additional indication: 24-week regimen for hepatitis C (genotype 1), low viral load, HCV RNA negative at 4 weeks",Treatment of chronic hepatitis C among previously untreated pediatric patients at least three years of age or older.
Fenfluramine,Fenfluramine,1,9/7/93,25/03/2022,—,Treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older
Fenfluramine,Fenfluramine Hci,0.95,9/7/93,25/06/2020,—,Fintepla (fenfluramine) is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.
Mesna,Mesna,1,1/12/81,30/12/1988,Urotoxic agent for prevention of urotoxic side effects with oxazaphosphorines in malignancy treatment,
Nimodipine,Nimodipine,1,31/08/1992,10/5/13,Treatment and prevention of ischaemic neurological deficit due to arterial spasm after subarachnoid haemorrhage,"Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in adult patients with subarachnoid hemorrhage (SAH) from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V)."
Pilocarpine,Pilocarpine,1,24/06/1999,22/03/1994,Management of intraocular pressure in glaucoma,Treatment of symptoms of xerostomia from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck.
Pilocarpine,Pilocarpine Hcl,0.9466666666666667,24/06/1999,11/2/98,Management of intraocular pressure in glaucoma,Treatment of dry mouth in patients with Sjogren's syndrome.
Vemurafenib,Vemurafenib,1,19/10/2012,17/08/2011,Treatment of unresectable/metastatic melanoma with BRAFV600E mutation,Treatment of unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test.
"Rosuvastatin, Fenofibrate",Rosuvastatin,0.9,23/08/2010,27/05/2016,Treatment of combined hyperlipidemia in patients with normal hepatic and renal function,"An adjunct to diet to reduce LDL-C, Total-C, nonHDL-C and ApoB in children and adolescents 7 to 17 years of age with homozygous familial hypercholesterolemia, either alone or with other lipid-lowering treatments (e.g., LDL apheresis)."
Apomorphine Hcl,Apomorphine Hcl,1,12/11/07,20/04/2004,Treatment of erectile dysfunction in adult men,"For the acute, intermittent treatment of hypomobility, ""off"" episodes (""end-of-dose-wearing-off"" and unpredictable :on/off"" episodes) associated with advanced Parkinson's disease"
Ganciclovir Sodium,Ganciclovir,0.9222222222222222,5/4/00,15/09/2009,Prevention and treatment of cytomegalovirus disease in immunocompromised and transplant patients,Treatment of acute herpetic keratitis (dendritic ulcers)
Ganciclovir Sodium,Ganciclovir Sodium,1,5/4/00,23/06/1989,Prevention and treatment of cytomegalovirus disease in immunocompromised and transplant patients,
Nilotinib,Nilotinib,1,14/07/2010,22/03/2018,Treatment of chronic and accelerated phase Philadelphia chromosome positive CML in adults resistant to or intolerant of imatinib,TASIGNA (nilotinib) is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase and pediatric patients greater than or equal to 1 year of age with chronic phase Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) with resistance or intolerance to prior tyrosine-kinase inhibitor (TKI) therapy.
Aprotinin,Aprotinin,1,27/05/1905,29/12/1993,,
Bedaquiline,Bedaquiline,1,14/01/2015,27/05/2020,Part of combination therapy for pulmonary multidrug-resistant tuberculosis in adults when effective regimen cannot otherwise be provided,SIRTURO is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multi-drug resistant tuberculosis (MDR-TB). Reserve SIRTURO for use when an effective treatment regimen cannot otherwise be provided.
Cinacalcet,Cinacalcet,1,16/01/2009,21/11/2014,Treatment of secondary hyperparathyroidism in CKD on dialysis and hypercalcemia in parathyroid carcinoma,"Treatment of hypercalcemia in adult patients with primary hyperparathyroidism for whom parathyroidectomy would be indicated on the basis of serum calcium levels, but who are unable to undergo parathyroidectomy."
Hydrocortisone Aceponate,Hydrocortisone,0.9166666666666667,6/1/17,29/09/2020,Symptomatic treatment of inflammatory and pruritic dermatosis in dogs,ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insufficiency
Sildenafil Citrate,Sildenafil,0.9111111111111111,8/1/01,31/01/2023,"Treatment of erectile dysfunction in men (by urologist, psychiatrist, endocrinologist)","treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in pediatric patients 1 to 17 years old to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underly improvements in exercise"
Temozolomide,Temozolomide,1,17/01/2000,15/03/2005,"Treatment of recurrent malignant glioma (glioblastoma multiforme, anaplastic astrocytoma) in adults",Treatment of adult patients with newly diagnosed glioblastoma multiforme concomitatly with radiotherapy and then as maintenance treatment
Glatiramer Acetate,Glatiramer Acetate,1,3/6/09,20/12/1996,Reduction of frequency of relapses in relapsing-remitting multiple sclerosis,For reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.
Meloxicam,Meloxicam,1,23/02/2015,11/8/05,Non-steroidal anti-inflammatory,For relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients 2 years of age or older
Melphalan,Melphalan,1,1/10/64,18/11/1992,Anti-cancer drug,For the palliative treatment of patients with multiple myeloma for whom oral melphalan is not appropriate.
Metronidazole,Metronidazole (Topical),0.9238095238095239,19/07/1993,22/11/1988,,
Acyclovir,Acyclovir,1,11/9/10,29/03/2019,Treatment of uncomplicated herpes zoster in immunocompetent patients,AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus.
Edaravone,Edaravone,1,27/07/2007,5/5/17,"Improvement of neurological symptoms, daily living disorder, and functional disorder in acute ischaemic stroke",Treatment of amyotrophic lateral sclerosis (ALS)
Lenvatinib,Lenvatinib,1,2/12/16,15/08/2018,Treatment of locally recurrent/metastatic progressive radioactive iodine refractory differentiated thyroid cancer,LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC)
Nitazoxanide,Nitazoxanide,1,17/03/2004,22/11/2002,,Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
Apomorphine,Apomorphine Hcl,0.9466666666666667,11/12/07,20/04/2004,Treatment of erectile dysfunction in adult men,"For the acute, intermittent treatment of hypomobility, ""off"" episodes (""end-of-dose-wearing-off"" and unpredictable :on/off"" episodes) associated with advanced Parkinson's disease"
Pemetrexed Disodium,Pemetrexed Disodium,1,8/10/08,4/2/04,"In combination with cisplatin, first-line treatment of advanced/metastatic non-small cell lung cancer (non-squamous)",Treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery
"Ifosfamide, Mesna",Ifosfamide,0.925,30/07/1999,30/12/1988,,"In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer."
Mebendazole,Mebendazole,1,1/12/74,19/10/2016,,treatment of patients one year of age and older withgastrointestinal infections caused by Ascaris lumbricoides (roundworm) and Trichuris trichiura (whipworm)
Pirfenidone,Pirfenidone,1,14/09/2010,15/10/2014,Treatment of idiopathic pulmonary fibrosis,Treatment of idiopathic pulmonary fibrosis
Trifluridine,Trifluridine/Tipiracil,0.9090909090909091,8/12/11,22/02/2019,Treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus types 1 and 2,"LONSURF is indicated for the treatment of adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy."
Bosentan,Bosentan,1,23/06/2009,5/9/17,Treatment of pulmonary arterial hypertension (WHO Group I) in patients with class III or IV symptoms to improve exercise ability and decrease clinical worsening,"Treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability"
Pazopanib,Pazopanib,1,23/02/2015,26/04/2012,Treatment of advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy,Advanced soft tissue sarcoma (STS) who have received prior chemotherapy
Triclabendazole,Triclabendazole,1,1/9/88,13/02/2019,"Broad spectrum flukicide for treatment of chronic fascioliasis (F. gigantica, F. hepatica) in livestock",EGATEN is indicated for the treatment of fascioliasis in patients 6 years of age and older.
Baclofen,Baclofen,1,22/02/2007,25/06/1992,As approved,Management of severe spasticity of spinal cord origin in patients who are unresponsive to oral baclofen therapy or experience intolerable CNS side effects at effective doses.
Bleomycin,Bleomycin Sulfate,0.9058823529411765,1/10/78,20/02/1996,For cancer specialists,Treatment of malignant pleural effusion.
"Dexamethasone, Indomethacin",Dexamethasone,0.9,1/11/71,3/10/19,—,HEMADY is indicated in combination with other anti-myeloma products for the treatment of adults with multiple myeloma
Eribulin Mesylate,Eribulin Mesylate,1,18/02/2015,28/01/2016,Treatment of locally advanced or metastatic breast cancer after at least one prior chemotherapy regimen,Treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracyclne-containing regimen
Mitomycin-C,Mitomycin,0.9636363636363636,1/12/72,15/04/2020,—,JELMYTO is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC)
Mitomycin-C,Mitomycin-C,1,1/12/72,7/2/12,—,An adjunct to ab externo glaucoma surgery.
Hydrocortisone,Hydrocortisone,1,9/8/99,29/09/2020,Adjunctive therapy in topical treatment of ulcerative proctitis of distal rectum in ulcerative colitis and proctosigmoiditis,ALKINDI SPRINKLE is indicated as replacement therapy in pediatric patients with adrenocortical insufficiency
Hydroxyurea,Hydroxyurea,1,1/4/04,25/02/1998,,To reduce the frequency of painful crises and to reduce the need for blood transfusions in adult patients with sickle cell anemia with recurrent moderate to severe painful crises (generally at least 3 during the preceding 12 months).
Desmopressin Acetate,Desmopressin Acetate,1,12/12/08,7/3/94,"Treatment of cranial diabetes insipidus, primary nocturnal enuresis",Treatment of patients with hemophilia A or von Willebrand's disease (type I) whose factor VIII coagulant activity level is greater than 5%.
"Mifepristone, Misoprostol",Mifepristone,0.9,16/12/2008,17/02/2012,Medical termination of intrauterine pregnancy up to 63 days gestation,for the control of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery.
Crizotinib,Crizotinib,1,16/12/2011,11/3/16,Treatment of ALK-positive locally advanced/metastatic non-small cell lung cancer (NSCLC),Treatment of patients with metastatic NSCLC whose tumors are ROS1-positive
Zidovudine,Zidovudine,1,18/12/1998,19/03/1987,Additional strength for HIV,Management of certain adult patients with symptomatic HIV infection (AIDS and advanced ARC) who have a history of cytologically confirmed Pneumocytis carinii pneumonia (PCP) or an absolute CD4 (T4 helper/induccer) lymphocyte count of less than 200/mm in the peripheral blood before therapy is begun
Botulinum Toxin Type A,Botulinum Toxin Type A,1,13/01/1994,29/12/1989,"Treatment of blepharospasm, hemifacial spasm, and focal dystonias",Treatment of strabismus associated with dystonia in adults (patients 12 years of age and above)
Botulinum Toxin Type A,Botulinum Toxin Type B,0.9818181818181818,13/01/1994,8/12/00,"Treatment of blepharospasm, hemifacial spasm, and focal dystonias",Treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
Clonidine Hcl,Clonidine,0.9384615384615385,1/2/75,2/10/96,Treatment of hypertension,In combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.
Cytarabine,Cytarabine Liposomal,0.9,1/6/80,1/4/99,Anticancer agent used in treatment of acute myeloid leukemia,Intrathecal treatment of lymphomatous meningitis.
Eltrombopag,Eltrombopag,1,19/10/2010,16/11/2018,Treatment of chronic immune thrombocytopenic purpura (ITP) in patients unresponsive to other therapies,PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
Tranexamic Acid,Tranexamic Acid,1,6/6/03,30/12/1986,"Abnormal bleeding associated with local hyperfibrinolysis (e.g. pulmonary hemorrhage, epistaxis, renal bleeding, prostate surgery)",Treatment of patients with hemophilia for short term use (2 to 8 days) before and after tooth extraction to reduce or prevent hemorrhage abd reduce the need for replacement therapy
Artesunate,Artesunate,1,2/7/14,26/05/2020,Treatment of severe falciparum malaria in quinine-resistant areas,Artesunate for Injection is indicated for the initial treatment of severe malaria in adult and pediatric patients. Treatment of severe malaria with Artesunate for Injection should always be followed by a complete treatment course of an appropriate oral antimalarial regimen.
Dexrazoxane,Dexrazoxane,1,26/02/2002,6/9/07,Prevention of cardiotoxicity from doxorubicin-based chemotherapy,Treatment of extravasation resulting from IV anthracycline chemotherapy
Fomepizole,Fomepizole,1,14/03/2016,8/12/00,"Antidote for ethylene glycol or methanol poisoning, alone or with hemodialysis","Use for suspected or confirmed methanol poisoning, either alone or in combination with hemodialysis"
Pegaspargase,Pegaspargase,1,7/3/14,1/2/94,Treatment of acute lymphoblastic leukemia in patients hypersensitive to asparaginase,Combination chemotherapy for the treatment of patients with acute lymphoblastic leukemia who are hypersensitive to native forms of L-asparaginase.
Amifostine,Amifostine,1,3/5/01,8/12/95,Approved for import as finished formulation,To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
Fluocinolone Acetonide,Fluocinolone,0.9090909090909091,1/8/62,8/4/05,Corticosteroid,Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye
Sterile,Sterile Talc,0.9166666666666667,18/04/2012,1/5/17,Nutritional supplement for malnourished renal failure patients on peritoneal dialysis,Steritalc is indicated in adults to decrease the recurrence of pneumothorax.
Temsirolimus,Temsirolimus,1,15/12/2010,30/05/2007,Treatment of advanced renal cell carcinoma,Treatment of advanced renal cell carcinoma
Propranolol,Propranolol,1,1/12/87,14/03/2014,,Treatment of proliferating infantile hemangioma requiring systemic therapy.
Somatropin,Somatropin,1,5/9/94,30/12/1996,Treatment of short stature due to pituitary growth hormone deficiency,Treatment of short stature associated with Turner syndrome in patients whose epiphyses are not closed.
Somatropin,Somatropin For,0.9428571428571428,5/9/94,23/08/1996,Treatment of short stature due to pituitary growth hormone deficiency,Treatment of AIDS wasting or cachexia.
Somatropin,Somatropin [Rdna],0.9333333333333333,5/9/94,25/07/2001,Treatment of short stature due to pituitary growth hormone deficiency,For long-term treatment of growth failure in children born small for gestational age who fail to manifest catch-up growth by two years of age.
Ivabradine,Ivabradine,1,19/12/2013,22/04/2019,Treatment of chronic heart failure with systolic dysfunction in sinus rhythm patients,"Corlanor is indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate."
Lamotrigine Er,Lamotrigine,0.9571428571428571,6/8/12,24/08/1998,Add-on therapy for partial and secondary generalized tonic-clonic seizures,Adjunctive treatment of Lennox-Gastaut syndrome in pediatric and adult patients.
Altretamine,Altretamine,1,29/03/1995,26/12/1990,Palliative treatment of persistent or recurrent ovarian cancer after first-line therapy with cisplatin and/or alkylating agents,Single agent palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent based combination.
Bleomycin Sulfate,Bleomycin Sulfate,1,11/10/99,20/02/1996,Treatment of malignant skin tumors,Treatment of malignant pleural effusion.
Epirubicin,Epirubicin,1,1/7/86,15/09/1999,"Treatment of breast cancer, malignant lymphomas, soft tissue sarcoma, gastric, lung, and ovarian carcinomas",Component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer.
Sorafenib Tosylate,Sorafenib,0.9,25/09/2014,16/11/2007,Treatment of advanced or metastatic differentiated thyroid carcinoma refractory to radioactive iodine,Treatment of unresectable hepatocellular carcinoma
Clobazam,Clobazam,1,11/11/97,21/10/2011,Treatment of anxiety and as adjunct therapy for refractory epilepsy,Adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome inpatients 2 years of age or older
Glycopyrrolate,Glycopyrrolate,1,1/12/79,28/07/2010,Preoperative antimuscarinic to reduce secretions and arrhythmias,To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy)
Arsenic Trioxide,Arsenic Trioxide,1,6/12/03,12/1/18,Treatment of acute promyelocytic leukemia (remission and consolidation),In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression.
Filgrastim,Filgrastim,1,28/06/2001,15/06/1994,Reduction of chemotherapy-induced neutropenia,Reduce the duration of neutropenia and neutropenia sequelae in patients with non-myeloid malignancies undergoing ablative chemotherapy followed by BMT.
Carfilzomib,Carfilzomib,1,17/01/2017,20/07/2012,Treatment of relapsed or refractory multiple myeloma in combination therapies,Treatment of patients with multiple myeloma who have received at least two prior therapies including bortezomib and an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Plerixafor,Plerixafor,1,31/01/2012,15/12/2008,Used with G-CSF to mobilize hematopoietic stem cells in non-Hodgkin’s lymphoma and multiple myeloma,To enhance mobilization of hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with lymphoma and multiple myeloma
Regorafenib,Regorafenib,1,1/7/14,25/02/2013,Treatment of metastatic colorectal cancer after prior therapies,"Treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate."
Sildenafil,Sildenafil,1,23/01/2007,31/01/2023,Treatment of pulmonary arterial hypertension (WHO Group I) to improve exercise ability,"treatment of pulmonary arterial hypertension (PAH) (WHO Group I) in pediatric patients 1 to 17 years old to improve exercise ability and, in pediatric patients too young to perform standardized exercise testing, pulmonary hemodynamics thought to underly improvements in exercise"
Tetrabenazine,Tetrabenazine,1,10/3/99,15/08/2008,"Treatment of movement disorders including Huntington’s chorea, hemiballismus, senile chorea",Treatment of chorea associated with Huntington's disease
Sotalol,Sotalol (,1,1/8/78,2/7/09,"Treatment of angina pectoris, hypertension, and cardiac arrhythmias","For use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of normal sinus rhythm in patients with history of highly symptomatic atrial fibrillation /flutter, and for treatment of documented life-threatening ventricular arrhythmias]"
Sotalol,Sotalol Hcl,0.9272727272727272,1/8/78,30/10/1992,"Treatment of angina pectoris, hypertension, and cardiac arrhythmias",Treatment of life-threatening ventricular tachyarrhythmias
Calfactant,Calfactant,1,16/12/2010,1/7/98,Treatment and prophylaxis of respiratory distress syndrome in premature infants,Treatment and prevention of respiratory failure due to pulmonary surfactant deficiency in preterm infants.
Diazoxide,Diazoxide Choline,0.9058823529411765,1/8/78,26/03/2025,Treatment of malignant hypertension,treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS)
Megestrol Acetate,Megestrol Acetate,1,5/12/12,10/9/93,"Treatment of anorexia, cachexia, and weight loss in cancer or AIDS patients","Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome."
Terlipressin,Terlipressin,1,22/07/1995,14/09/2022,Treatment of bleeding esophageal varices,To improve kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function
Ifosfamide,Ifosfamide,1,1/9/78,30/12/1988,"Treatment of various cancers including ovarian, breast, testicular, pancreas, and lymphoma","In combination with certain other approved antineoplastic agents, for third line chemotherapy in the treatment of germ cell testicular cancer."
Moxidectin,Moxidectin,1,16/01/1997,7/2/25,Treatment and control of parasites in cattle,treatment of onchocerciasis due to Onchocerca volvulus in adult and pediatric patients aged 4 years and older and weighing at least 13 kg
Infliximab,Infliximab,1,15/07/2004,19/05/2006,Maintenance therapy for Crohn's disease and fistulizing Crohn’s,For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy
Triptorelin,Triptorelin Pamoate,0.9157894736842105,5/7/93,29/06/2017,"Treatment of prostate, ovarian, breast cancer, precocious puberty, uterine fibroids, PCOS, and IVF pre-treatment",Treatment of pediatric patients 2 years of age and older with central precocious puberty
Zalcitabine,Zalcitabine,1,26/07/1993,19/06/1992,Treatment of AIDS,Combination therapy with zidovudine is indicated for the treatment of adult patients with advanced HIV infection (CD4 count < 300) who have demonstrated malignant clinical or immunologic deterioration.
Irinotecan,Irinotecan Liposome,0.9052631578947368,23/05/1997,13/02/2024,Treatment of colorectal cancer,"in combination with oxaliplatin, fluorouracil and leucovorin for the first-line treatment of adult patients with metastatic pancreatic adenocarcinoma"
Dabrafenib,Dabrafenib,1,18/01/2017,16/03/2023,Monotherapy or in combination for unresectable/metastatic BRAF V600E-positive melanoma,"in combination with trametinib, for the treatment of pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy"
Dichlorphenamide,Dichlorphenamide,1,1/1/64,7/8/15,Carbonic anhydrase inhibitor,"Treatment of primary hyperkalemic periodic paralysis, primary hypokalemic period paralysis, and related variants"
Difluprednate,Difluprednate,1,1/4/10,13/06/2012,Treatment of inflammation and pain associated with ocular surgery,Treatment of endogenous anterior uveitis
Pasireotide,Pasireotide,1,18/03/2015,14/12/2012,Treatment of Cushing’s disease in non-surgical candidates,Treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative
Deflazacort,Deflazacort,1,30/01/2010,7/6/19,Same as approved,EMFLAZA is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
"Nitazoxanide, Ofloxacin",Nitazoxanide,0.9090909090909091,1/7/05,22/11/2002,"Treatment of enterocolitis, urogenital, and other susceptible infections",Treatment of diarrhea caused by Cryptosporidium parvum and Giardia lamblia
Midazolam Maleate,Midazolam,0.9058823529411765,5/7/05,17/05/2019,Bulk anesthetic agent,"NAYZILAM is indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patients usual seizure pattern in patients with epilepsy 12 years of age and older."
Riluzole,Riluzole,1,17/10/1997,12/12/95,Treatment of amyotrophic lateral sclerosis (ALS),Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy.
Basiliximab,Basiliximab,1,28/05/1999,12/5/98,Prophylaxis of acute organ rejection in transplantation with cyclosporin and corticosteroids,Prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine and corticosteroids.
Mefloquine,Mefloquine Hcl,0.9428571428571428,3/3/97,3/5/89,Treatment of severe and chloroquine-resistant malaria including cerebral malaria,Prophylaxis of Plasmodium falciparum malaria which is resistant to other available drugs
Trametinib,Trametinib,1,18/01/2017,29/05/2013,"Treatment of unresectable or metastatic melanoma with BRAF V600E mutation, as monotherapy or with Dabrafenib",Treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations as detected by an FDA approved test.
Icodextrin,Icodextrin,1,8/6/06,20/12/2002,Peritoneal dialysis for renal failure,For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal failure.
Interferon Alfa-2B,Interferon Alfa-2A,0.9777777777777777,27/12/2000,19/10/1995,"Treatment of cancers including multiple myeloma, Kaposi’s sarcoma, melanoma, leukemia, and other malignancies (specialist only)",Treatment of chronic myelogenous leukemia.
Interferon Alfa-2B,Interferon Alfa-2A (Recombinant),0.92,27/12/2000,21/11/1988,"Treatment of cancers including multiple myeloma, Kaposi’s sarcoma, melanoma, leukemia, and other malignancies (specialist only)",
Interferon Alfa-2B,Interferon Alfa-2B (Recombinant),0.92,27/12/2000,21/11/1988,"Treatment of cancers including multiple myeloma, Kaposi’s sarcoma, melanoma, leukemia, and other malignancies (specialist only)",Treatment of selected patients with AIDS-related Kaposi's sarcoma.
"Glycopyrrolate, Neostigmine",Glycopyrrolate,0.9076923076923077,11/4/02,28/07/2010,Reversal of neuromuscular block,To reduce chronic drooling in patients aged 3 - 16 with neurologic conditions associated with problem drooling (e.g. cerebral palsy)
Fludarabine Phosphate,Fludarabine Phosphate,1,22/06/1999,18/04/1991,Treatment of B-cell chronic lymphocytic leukaemia in patients unresponsive to standard alkylating agent regimens,
Alectinib,Alectinib,1,23/01/2017,18/04/2024,Treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) after progression on or intolerance to Crizotinib,"adjuvant treatment in adult patients following tumor resection of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumors greater than or equal to 4 cm or node positive), as detected by an FDA-approved test"
Panobinostat,Panobinostat,1,27/03/2016,23/02/2015,In combination with bortezomib and dexamethasone for treatment of multiple myeloma after at least one prior therapy,"FARYDAK (panobinostat) in combination with bortezomib (BTZ) and dexamethasone (DEX) for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent"
Rituximab,Rituximab,1,10/7/00,27/09/2019,Treatment of relapsed or chemo-resistant indolent B-cell NHL (specialist use),"RITUXAN, in combination with glucocorticoids, is indicated for the treatment of adult and pediatric patients 2 years of age and older with Granulomatosis with Polyangiitis (GPA) (Wegener?s Granulomatosis) and Microscopic Polyangiitis (MPA)"
Eliglustat,Eliglustat,1,31/01/2017,19/08/2014,Treatment of Gaucher disease type 1 in appropriate CYP2D6 phenotypes,"Long-term treatment of adult patients with Gaucher disease type 1 who are CYP2D6 extensive metabolizers (EMs), intermediate metabolizers (IMs), or poor metabolizers (PMs) as detected by an FDA-cleared test."
Nafarelin,Nafarelin Acetate,0.9058823529411765,17/03/1999,26/02/1992,Treatment of endometriosis and central precocious puberty,Treatment of central precocious puberty (gonadotropin-dependent precocious puberty) in children of both sexes.
Trastuzumab,Trastuzumab,1,10/7/00,20/10/2010,Treatment of HER2-positive metastatic breast cancer,"Treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma, who have not received prior treatment for metastatic disease"
Modafinil,Modafinil,1,16/12/2003,24/12/1998,By neurologist/psychiatrist – to improve wakefulness in narcolepsy,Improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy.
Thalidomide,Thalidomide,1,12/8/02,25/05/2006,Treatment of erythema nodosum leprosum and multiple myeloma,Treatment of patients with newly diagnosed multiple myeloma
Daclizumab,Daclizumab,1,12/10/00,10/12/97,Prophylaxis in acute organ rejection in transplant patients (hospital use only),"Prophylaxis of acute organ rejection in patients receiving renal transplants, to be used as a part of an immunosuppressive regimen that includes cyclosporine and corticosteroids."
Ceritinib,Ceritinib,1,3/7/15,26/05/2017,Treatment of ALK-positive metastatic non-small cell lung cancer intolerant to or progressed on crizotinib,Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test
"Megestrol Acetate, Ethinylestradiol",Megestrol Acetate,0.9,1/4/67,10/9/93,Oral contraceptive,"Treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immune deficiency syndrome."
Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,1,12/9/02,17/05/2000,Treatment of acute myeloid leukemia,Treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for cytotoxic chemotherapy
Cladribine,Cladribine,1,9/9/03,26/02/1993,Treatment of cancer,
Teriparatide,Teriparatide,1,4/9/03,23/12/1987,Treatment of osteoporosis,
Beractant,Beractant,1,2/10/00,2/7/91,Treatment and prevention of neonatal respiratory distress syndrome,Prevention of RDS (hyaline membrane disease) in premature infants less than 1250 grams birthweight or with evidence of surfactant deficiency